Clinical Trial Product
Device Clinical Trial Product_CRM
General payments
$272,763
Research payments
$15,455,776
Through program year 2025, $272,763 in general payments and $15,455,776 in research payments were reported against Clinical Trial Product (Clinical Trial Product_CRM).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
5 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $261,157 | 260 |
| 2025 | Research | $6,024,098 | 948 |
| 2024 | Research | $9,390,146 | 1,246 |
| 2022 | General | $11,606 | 80 |
| 2022 | Research | $41,532 | 23 |
Breakdown
The top 5 of 96 recipients; each share is of general payments naming this product in 2025.
The top 5 of 11 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 29 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
340 general · 2,217 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.